Word

TAAV

Status

Pending

Status Code

686

Status Date

Tuesday, May 14, 2024

Serial Number

79378254

Mark Type

4

Filing Date

Wednesday, August 2, 2023

Published for Opposition

Tuesday, May 14, 2024

Trademark Owner History

TAAV Biomanufacturing Solutions, S.L.U. - Owner At Publication

Classifications

5 Vaccines; DNA based vaccines; DNA extracts, namely, nucleic acid sequences and chemical reagents for medical use; therapeutic DNA, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; biotechnological product, namely, viral DNA vector for delivery of genes and other materials for medical purposes; biotechnological product, namely, RNA and transcriptional targeting promoters to a biological cell for medical purposes; DNA for production of viral vectors for medical and veterinary purposes; none of the aforesaid being or including cell growth media

1 Chemical preparations, enzymes and DNA for the preparation of nucleic acid for scientific research; chemicals for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; enzymes for use in the preparation and creation of DNA extracts and cassettes for scientific and industrial purposes; DNA extracts and cassettes for scientific and research use; DNA extracts for use in agri-biotechnology and nanotechnology other than for medical and veterinary purposes; biological and biochemical reagents forming a gene analysis system, namely, RNA polymerase, DNA plasmid vectors and RNA markers for scientific or research purposes; diagnostic reagents for scientific or research purposes, namely, a kit primarily composed of a DNA plasmid vectors; none of the aforesaid being or including cell growth media

42 Scientific and technological services, namely, research and design in the field of DNA research and development; chemical and biological analysis and research services; scientific research in the field of DNA; scientific research and development in the field of creation of DNA extracts; scientific research, analysis, design and development relating to DNA based pharmaceutical drugs and therapies; scientific research and development in the fields of gene therapy, diagnostics, agri-biotechnology and nanotechnology; consultancy in the fields of agri-biotechnology and nano technology; consultancy relating to scientific research and development in the fields of gene therapy, diagnostics and DNA analysis; none of the aforesaid services relating to cell growth media

Trademark Events

Sep 8, 2023

New Application Office Supplied Data Entered

Sep 12, 2023

Application Filing Receipt Mailed

Apr 3, 2024

Assigned To Examiner

Apr 11, 2024

Approved For Pub - Principal Register

Apr 24, 2024

Notification Of Possible Opposition Sent To Ib

Apr 24, 2024

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 24, 2024

Notice Of Publication

May 13, 2024

Notification Processed By Ib

May 14, 2024

Published For Opposition

Sep 7, 2023

Sn Assigned For Sect 66a Appl From Ib